D015214Chemicals & DrugsD23.050.301.264.900D23.101.100.90025320.987103Antigens, Differentiation, Myelomonocyticprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentvivo:hrJobTitleHR job titleInformation Resourcevivo:orcidIdORCID idPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson28358264Leclerc JL, Lampert AS, Loyola Amador C, Schlakman B, Vasilopoulos T, Svendsen P, Moestrup SK, Doré SJournal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and MetabolismThe absence of the CD163 receptor has distinct temporal influences on intracerebral hemorrhage outcomes. J Cereb Blood Flow Metab. 2018 02; 38(2):262-273.J Cereb Blood Flow Metab2017-03-30T00:00:002017The absence of the CD163 receptor has distinct temporal influences on intracerebral hemorrhage outcomes.0.3926250.0060194425research area of0.6450830.024392437subject area forMedicine-Hematology and OncologyObstetrics and Gynecology-Gynecologic OncologyJunkoMatsuzakiJunko Matsuzaki41.7886000000000087.598699999999994019Matsuzaki, Junko0000-0002-2555-1234Research Professor21148721Thenappan T, Goel A, Marsboom G, Fang YH, Toth PT, Zhang HJ, Kajimoto H, Hong Z, Paul J, Wietholt C, Pogoriler J, Piao L, Rehman J, Archer SLAmerican journal of respiratory and critical care medicineA central role for CD68(+) macrophages in hepatopulmonary syndrome. Reversal by macrophage depletion. Am J Respir Crit Care Med. 2011 Apr 15; 183(8):1080-91.Am J Respir Crit Care Med2010-12-10T00:00:002010A central role for CD68(+) macrophages in hepatopulmonary syndrome. Reversal by macrophage depletion.16116598Larson RA, Sievers EL, Stadtmauer EA, Löwenberg B, Estey EH, Dombret H, Theobald M, Voliotis D, Bennett JM, Richie M, Leopold LH, Berger MS, Sherman ML, Loken MR, van Dongen JJ, Bernstein ID, Appelbaum FRCancerFinal report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33-positive acute myeloid leukemia in first recurrence. Cancer. 2005 Oct 01; 104(7):1442-52.Cancer2005-10-01T00:00:002005Final report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33-positive acute myeloid leukemia in first recurrence.DavidZemmourDavid Zemmour41.7886000000000087.598699999999994174Zemmour, DavidAssistant Professor29191879Engblom C, Pfirschke C, Zilionis R, Da Silva Martins J, Bos SA, Courties G, Rickelt S, Severe N, Baryawno N, Faget J, Savova V, Zemmour D, Kline J, Siwicki M, Garris C, Pucci F, Liao HW, Lin YJ, Newton A, Yaghi OK, Iwamoto Y, Tricot B, Wojtkiewicz GR, Nahrendorf M, Cortez-Retamozo V, Meylan E, Hynes RO, Demay M, Klein A, Bredella MA, Scadden DT, Weissleder R, Pittet MJScience (New York, N.Y.)Osteoblasts remotely supply lung tumors with cancer-promoting SiglecFhigh neutrophils. Science. 2017 12 01; 358(6367).Science2017-12-01T00:00:002017Osteoblasts remotely supply lung tumors with cancer-promoting SiglecFhigh neutrophils.MedicinePathologyUniversity of ChicagoRichard A.LarsonRichard A. Larson41.78927490000000-87.601250000000001169Larson, Richard A.ProfessorStephenArcherStephen Archer41.78927490000000-87.601250000000002615Archer, StephenProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1Research ProfessorResearch Professortrue1Assistant ProfessorAssistant Professortrue1ProfessorProfessorDanielArberDaniel Arber0.000000000000000.000000000000003406Arber, DanielProfessor15832085Nguyen TT, Schwartz EJ, West RB, Warnke RA, Arber DA, Natkunam YThe American journal of surgical pathologyExpression of CD163 (hemoglobin scavenger receptor) in normal tissues, lymphomas, carcinomas, and sarcomas is largely restricted to the monocyte/macrophage lineage. Am J Surg Pathol. 2005 May; 29(5):617-24.Am J Surg Pathol2005-05-01T00:00:002005Expression of CD163 (hemoglobin scavenger receptor) in normal tissues, lymphomas, carcinomas, and sarcomas is largely restricted to the monocyte/macrophage lineage.